Authors

• Zhuang Tian
• Yi‐Da Tang (ORCID: https://orcid.org/0000-0002-9712-803X)
• Naihan Chen (ORCID: https://orcid.org/0000-0002-7145-0776)
• Jiangtao Yan
• Wei Ma (ORCID: https://orcid.org/0000-0003-1305-3980)
• Ying Liu (ORCID: https://orcid.org/0000-0002-9071-1310)
• Jianan Wang (ORCID: https://orcid.org/0000-0002-4583-3204)
• Wei Jin (ORCID: https://orcid.org/0000-0002-2905-2109)
• Daoquan Peng (ORCID: https://orcid.org/0000-0002-1185-6475)
• Xiaohong Sun (ORCID: https://orcid.org/0000-0001-8571-8596)
• Shuiqing Zhu
• Yingxu Gao
• Shuyang Zhang
• Caiping Jia
• Yankun Gong

Institutions

• Central South University (CN)
• Dalian Medical University (CN)
• Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
• Peking University (CN)
• Peking Union Medical College Hospital (CN)
• Ruijin Hospital (CN)
• Peking University First Hospital (CN)
• First Affiliated Hospital of Dalian Medical University (CN)
• Peking University Third Hospital (CN)
• Pfizer (China) (CN)
• Second Xiangya Hospital of Central South University (CN)
• Second Affiliated Hospital of Zhejiang University (CN)
• Tongji Hospital (CN)
• Huazhong University of Science and Technology (CN)

Publication Details

Journal

Cardiology and Therapy

Published

2025-05-23

DOI

https://doi.org/10.1007/s40119-025-00408-6

Primary Topic

Amyloidosis: Diagnosis, Treatment, Outcomes

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Pfizer